AstraZeneca: appointment on board of directors
(CercleFinance.com) - On Monday AstraZeneca announced the appointment of Michel Demaré to its board of directors.
He is a Belgian businessman who has spent most of his career in the industrial sector.
After graduating from the Université Catholique de Louvain, Michel Demaré worked at the American chemist Dow Chemical and was then CFO at the Swiss-Swedish engineering group ABB.
As Vice Chairman of the Board of Directors of the Swiss investment bank UBS between 2010 and 2019, he currently sits on Vodafone's Board of Directors, as well as on the Supervisory Board of Louis Dreyfus.
Michel Demaré will join AstraZeneca's audit committee.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
He is a Belgian businessman who has spent most of his career in the industrial sector.
After graduating from the Université Catholique de Louvain, Michel Demaré worked at the American chemist Dow Chemical and was then CFO at the Swiss-Swedish engineering group ABB.
As Vice Chairman of the Board of Directors of the Swiss investment bank UBS between 2010 and 2019, he currently sits on Vodafone's Board of Directors, as well as on the Supervisory Board of Louis Dreyfus.
Michel Demaré will join AstraZeneca's audit committee.
Copyright (c) 2019 CercleFinance.com. All rights reserved.